Updates

TClarke

June 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

At the AGM, TClarke told shareholders it is on track for sales to exceed £500m in the current year, supported by the order book, which now stands at £720m (2022: £585m). TClarke added that a keynote when compared to previous years is the increased visibility of its revenues outside of London, through the growth of its work in the healthcare sector and larger projects. Cenkos forecasts eps of 18.9p for the current year to end December and has introduced an estimate of 23.9p for next year, for a PE of 6.4. H1 results are due on 13 July. Finally a few signs of life sending the shares higher. Strong hold. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

H&T

Luceco - Cluster buying by directors

TClarke - 160p cash offer from Regent Gas (May 2024)

TClarke (April 2024)

TClarke (August 2023)

T Clarke (February 2023)

T Clarke (December 2022)

T Clarke (August 2022)

T Clarke - High confidence to beat forecasts (June 2022)

T Clarke - Eps of 21.1p forecast this year (April 2022)

T Clarke - Record Q4 for sales and no supply chain issues (December 2021)

T Clarke - Data centre wins balloon order book to £503m (September 2021)

T Clarke - Cash adjusted PE of 4.7 (February 2017)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X